Cargando…

Gender Differences in Diabetic Kidney Disease: Focus on Hormonal, Genetic and Clinical Factors

Diabetic kidney disease (DKD) is one of the most serious complications of both type 1 (T1DM) and type 2 diabetes mellitus (T2DM). Current guidelines recommend a personalized approach in order to reduce the burden of DM and its complications. Recognizing sex and gender- differences in medicine is con...

Descripción completa

Detalles Bibliográficos
Autores principales:	Giandalia, Annalisa, Giuffrida, Alfio Edoardo, Gembillo, Guido, Cucinotta, Domenico, Squadrito, Giovanni, Santoro, Domenico, Russo, Giuseppina T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8198374/ https://www.ncbi.nlm.nih.gov/pubmed/34071671 http://dx.doi.org/10.3390/ijms22115808

Ejemplares similares

The Aggressive Diabetic Kidney Disease in Youth-Onset Type 2 Diabetes: Pathogenetic Mechanisms and Potential Therapies
por: Amatruda, Michela, et al.
Publicado: (2021)

Potential Role of Copper in Diabetes and Diabetic Kidney Disease
por: Gembillo, Guido, et al.
Publicado: (2022)

Fracture Risk in Type 2 Diabetes: Current Perspectives and Gender Differences
por: Russo, Giuseppina T., et al.
Publicado: (2016)

Corrigendum to “Fracture Risk in Type 2 Diabetes: Current Perspectives and Gender Differences”
por: Russo, Giuseppina T., et al.
Publicado: (2017)

Role of Zinc in Diabetic Kidney Disease
por: Gembillo, Guido, et al.
Publicado: (2022)

Methotrexate Increases Skeletal Muscle GLUT4 Expression and Improves Metabolic Control in Experimental Diabetes
por: Russo, Giuseppina T., et al.
Publicado: (2012)

Long-Term Influence of Locus of Control and Quality of Life on Metabolic Profile in Elderly Subjects with Type 2 Diabetes
por: Giandalia, Annalisa, et al.
Publicado: (2022)

Personalized Medicine in Kidney Disease
por: Gembillo, Guido, et al.
Publicado: (2023)

Markers of Systemic Inflammation and Apo-AI Containing HDL Subpopulations in Women with and without Diabetes
por: Russo, Giuseppina T., et al.
Publicado: (2014)

Kidney Disease in Diabetic Patients: From Pathophysiology to Pharmacological Aspects with a Focus on Therapeutic Inertia
por: Gembillo, Guido, et al.
Publicado: (2021)

Impact of Sex and Gender on Clinical Management of Patients with Advanced Chronic Liver Disease and Type 2 Diabetes
por: Licata, Anna, et al.
Publicado: (2023)

Influence of peroxisome proliferator-activated receptor-γ exon 2 and exon 6 and insulin receptor substrate (IRS)-1 Gly972Arg polymorphisms on insulin resistance and beta-cell function in southern mediterranean women with polycystic ovary syndrome
por: Giandalia, Annalisa, et al.
Publicado: (2018)

High Prevalence of Severe Hepatic Fibrosis in Type 2 Diabetic Outpatients Screened for Non-Alcoholic Fatty Liver Disease
por: Asero, Clelia, et al.
Publicado: (2023)

High Prevalence of Arcobacter Carriage in Older Subjects with Type 2 Diabetes
por: Fera, Maria Teresa, et al.
Publicado: (2010)

Glomerular Filtration Rate as a Predictor of Outcome in Acute Coronary Syndrome Complicated by Atrial Fibrillation
por: Santoro, Domenico, et al.
Publicado: (2020)

Vitamin D and Glomerulonephritis
por: Gembillo, Guido, et al.
Publicado: (2021)

Amyloidosis and Glomerular Diseases in Familial Mediterranean Fever
por: Siligato, Rossella, et al.
Publicado: (2021)

Lung Dysfunction and Chronic Kidney Disease: A Complex Network of Multiple Interactions
por: Gembillo, Guido, et al.
Publicado: (2023)

Immune Checkpoint Inhibitors and the Kidney: A Focus on Diagnosis and Management for Personalised Medicine
por: Longhitano, Elisa, et al.
Publicado: (2023)

Complement Inhibition Therapy and Dialytic Strategies in Paroxysmal Nocturnal Hemoglobinuria: The Nephrologist’s Opinion
por: Gembillo, Guido, et al.
Publicado: (2020)

GLP-1 Receptor Agonists and Kidney Protection
por: Greco, Eulalia Valentina, et al.
Publicado: (2019)

Antihypertensive Treatment in Diabetic Kidney Disease: The Need for a Patient-Centered Approach
por: Bonino, Barbara, et al.
Publicado: (2019)

Resistin levels and inflammatory and endothelial dysfunction markers in obese postmenopausal women with type 2 diabetes mellitus
por: Giandalia, A., et al.
Publicado: (2021)

Correlation between Hyperkalemia and the Duration of Several Hospitalizations in Patients with Chronic Kidney Disease
por: Calabrese, Vincenzo, et al.
Publicado: (2022)

Over time evaluation of glycaemic control in direct‐acting antiviral‐treated hepatitis C virus/diabetic individuals with chronic hepatitis or with cirrhosis
por: Cacciola, Irene, et al.
Publicado: (2021)

Trabecular bone score and phalangeal quantitative ultrasound are associated with muscle strength and fracture risk in hemodialysis patients
por: Catalano, Antonino, et al.
Publicado: (2022)

How to Choose the Right Treatment for Membranous Nephropathy
por: Peritore, Luigi, et al.
Publicado: (2023)

Chronic Kidney Disease Management in General Practice: A Focus on Inappropriate Drugs Prescriptions
por: Barbieri, Maria Antonietta, et al.
Publicado: (2020)

Kidney Biopsy in Type 2 Diabetic Patients: Critical Reflections on Present Indications and Diagnostic Alternatives
por: Santoro, Domenico, et al.
Publicado: (2021)

Role of Vitamin D Status in Diabetic Patients with Renal Disease
por: Gembillo, Guido, et al.
Publicado: (2019)

Diabetic kidney disease in the elderly: prevalence and clinical correlates
por: Russo, Giuseppina T., et al.
Publicado: (2018)

Factors Associated with Beta-Cell Dysfunction in Type 2 Diabetes: The BETADECLINE Study
por: Russo, Giuseppina T., et al.
Publicado: (2014)

Protective Role of Vitamin D in Renal Tubulopathies
por: Gembillo, Guido, et al.
Publicado: (2020)

Sex-Specific Impact of Different Obesity/Metabolic Phenotypes on Long-Term Cardiovascular Outcomes in Acute Coronary Syndrome Patients
por: Imbalzano, Egidio, et al.
Publicado: (2022)

Maternal and Fetal Outcomes of Pregnancy in Nephrotic Syndrome Due to Primary Glomerulonephritis
por: Siligato, Rossella, et al.
Publicado: (2020)

Cardiorenal Syndrome: New Pathways and Novel Biomarkers
por: Gembillo, Guido, et al.
Publicado: (2021)

Association of Higher Advanced Oxidation Protein Products (AOPPs) Levels in Patients with Diabetic and Hypertensive Nephropathy
por: Conti, Giovanni, et al.
Publicado: (2019)

Flavocoxid, a Natural Antioxidant, Protects Mouse Kidney from Cadmium-Induced Toxicity
por: Micali, Antonio, et al.
Publicado: (2018)

The Burden of Structured Self-Monitoring of Blood Glucose on Diabetes-Specific Quality of Life and Locus of Control in Patients with Noninsulin-Treated Type 2 Diabetes: The PRISMA Study
por: Russo, Giuseppina T., et al.
Publicado: (2016)

Kidney Disease Management in the Hospital Setting: A Focus on Inappropriate Drug Prescriptions in Older Patients
por: Arcoraci, Vincenzo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2o6tn4gca8dobeloagh8h24b4s